CARDAMYST Nasal spray Ref.[116097] Active ingredients: Etripamil
Source: FDA, National Drug Code (US) Revision Year: 2025
Product description
Etripamil, the active ingredient of CARDAMYST is a calcium channel blocker.
The chemical name of etripamil is benzoic acid, 3-[2-[[(4S)-4-cyano-4-(3,4-dimethoxyphenyl)-5-methylhexyl]methylamino]ethyl]-, methyl ester.
Its molecular weight is 452.59 and its molecular formula is C27H36N2O4.
The structural formula is:
Etripamil is a colorless to slightly yellow oil. Etripamil has a pKa of 8.57 and is very soluble in methyl tert-butyl ether, freely soluble in methanol, dichloromethane and acetone, sparingly soluble in ethanol and hexane, and insoluble in water.
CARDAMYST is a spray intended for nasal administration. Each device of CARDAMYST delivers two metered sprays of etripamil with a total of 70 mg. CARDAMYST contains 350 mg/mL of etripamil and the following inactive ingredients: acetic acid, edetate disodium, sulfuric acid for pH adjustment, and water for injection.
| Dosage Forms and Strengths |
|---|
|
Nasal Spray: Clear colorless to yellow solution. 70 mg of etripamil per device. |
| How Supplied |
|---|
|
CARDAMYST is supplied in cartons (NDC 83468-070-03) of 2 disposable nasal spray devices contained in a plastic carrying case. Each nasal spray device delivers two sprays containing a total of 70 mg etripamil. Manufactured for: Milestone Pharmaceuticals USA, Inc. 6210 Ardrey Kell Road, Suite 650, Charlotte, NC, 28277 |
Drugs
| Drug | Countries | |
|---|---|---|
| CARDAMYST | United States |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.